Other
Neoantigen
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Neoantigen is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Unknown status3 · 43%
Recruiting2 · 29%
Terminated1 · 14%
Completed1 · 14%
Clinical Trials
Trial Activity
7 trials
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
Recruiting·—·Phase 1·NCT03219450·15 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)